Neurovascular and Neurodegenerative diseases take a huge toll on world economy and health. According to the Brain Aneurysm Foundation, cerebral aneurysms affect a predictable 6 million Americans and are accountable for around half a million deaths globally each year. As per the stats shared in the report, “Neurological disorders: Public health challenges” there are around 50 million people who suffer from epilepsy and 24 million from Dementia globally. Neurovascular and Neurodegenerative diseases affect people worldwide, irrespective of sex, age, education or income.
Neurovascular and Neurodegenerative diseases can lead to various types of neurological conditions ranging from stroke to disability and death. These conditions have devastating effects on Public Health. There is a great need for the development of the new generation treatments and therapeutic options to combat these diseases.
The aim of 2nd International Conference on Neurovascular and Neurodegenerative Diseases is to bring together today’s global leaders working on various aspects of neurovascular as well as neurodegenerative diseases. The program of NVND-2019 will comprehensively discuss new results, state-of-the-art methodologies and technologies, and candidate therapeutics important to the development of the next generation treatments. The group of selected speakers from more than 40 countries will share their work on identifying new biomarkers, neuroimaging techniques, prognosis methods and effectiveness of new treatment options.
The emerging researcher’s forum and poster competition during the meeting will encourage young researchers to come forward and share their work and experience.
NVND-2019 will be great a platform to come together for a common cause and address the challenges in the recent development of effective treatments for variety of Neurovascular and Neurodegenerative Diseases.
USG United Scientific Group
A non-profit scientific organization
8105, Rasor Blvd - Suite #112
PLANO, TX 75024, USA
Tel: 408-426-4833, 408-426-4832
Toll Free: 844-395-4102 | Fax: 408-426-4869 firstname.lastname@example.org